AGC (5201) Q2 2025 earnings summary

Executive summary

• Net sales for the first half of FY2025 were ¥995.5 billion, down ¥19.7 billion year-over-year, mainly due to yen appreciation, lower shipments in Architectural Glass, and lower PVC resin prices, despite improved product mix and pricing in Automotive and Performance Chemicals.

• Operating profit declined by ¥2.7 billion to ¥54.0 billion, impacted by lower sales and rising raw material and fuel costs.

• Profit attributable to owners surged by ¥128.4 billion to ¥13.9 billion, driven by the absence of prior-year one-off losses from the Russian business transfer and biopharmaceutical CDMO impairment.

• Downward revision of FY2025 outlook due to underperformance in Chemicals, Life Science, and Electronics segments.

Financial highlights

• Full-year forecast revised downward: net sales expected at ¥2,050 billion (down ¥100 billion), operating profit at ¥120 billion (down ¥30 billion), and net income at ¥57 billion (down ¥23 billion).

• Operating cash flow was ¥117.1 billion; investing cash flow was ¥-87.7 billion, resulting in free cash flow of ¥29.4 billion.

• CapEx was ¥96.9 billion, depreciation ¥88.2 billion, and R&D ¥28.5 billion.

• Operating profit margin for 1H FY2025 was 5.4%, with ROE at 4.0%.

• Interim dividend confirmed at ¥105 per share; full-year forecast unchanged at ¥210.

Outlook and guidance

• FY2025 net sales forecast revised to ¥2,050 billion, operating profit to ¥120 billion, and profit attributable to owners to ¥57 billion.

• Segment outlook: Automotive and Performance Chemicals expected to grow, while Life Science and Electronics face headwinds.

• FX assumptions updated to ¥147/USD and ¥163/EUR.

• ROE target of 5% or higher in 2026, with structural reforms and cost reductions planned.

• Second half expected to see improved profitability in Architectural Glass (Japan/Asia), stable South America, continued European weakness, and seasonal declines in Automotive.